205 related articles for article (PubMed ID: 36701854)
1. Recombinant tissue plasminogen activator (rTPA) management for first onset acute ischemic stroke with covid -19 and non-covid -19 patients.
Khedr EM; Abdelwarith A; Moussa G; Saber M
J Stroke Cerebrovasc Dis; 2023 Apr; 32(4):107031. PubMed ID: 36701854
[TBL] [Abstract][Full Text] [Related]
2. Low-dose intravenous recombinant tissue plasminogen activator in acute ischemic stroke without large vessel occlusion screened by 3T MRI.
Huynh QS; Tran CC; Nguyen-Thi HT; Nguyen TT; Phan-Thi HL; Luu-Dang DT; Le MT; Nguyen MD
Eur Rev Med Pharmacol Sci; 2023 Jul; 27(14):6554-6562. PubMed ID: 37522667
[TBL] [Abstract][Full Text] [Related]
3. Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience.
Sallustio F; Koch G; Di Legge S; Rossi C; Rizzato B; Napolitano S; Samà D; Arnò N; Giordano A; Tropepi D; Misaggi G; Diomedi M; Del Giudice C; Spinelli A; Fabiano S; Stefanini M; Konda D; Reale CA; Pampana E; Simonetti G; Stanzione P; Gandini R
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e323-31. PubMed ID: 23379980
[TBL] [Abstract][Full Text] [Related]
4. Association of admission neutrophil serine proteinases levels with the outcomes of acute ischemic stroke: a prospective cohort study.
Li L; Han Z; Wang R; Fan J; Zheng Y; Huang Y; Yang Z; Yan F; Liu P; Zhao H; Ma Q; Luo Y
J Neuroinflammation; 2023 Mar; 20(1):70. PubMed ID: 36906528
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a modified intravenous recombinant tissue plasminogen activator regimen in Chinese patients with acute ischemic stroke.
Pan SM; Liu JF; Liu M; Shen S; Li HJ; Dai LH; Chen XJ
J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):690-3. PubMed ID: 23111010
[TBL] [Abstract][Full Text] [Related]
6. Acute stroke management in the elderly.
Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
[TBL] [Abstract][Full Text] [Related]
7. A 2-point difference of NIHSS as a predictor of acute ischemic stroke outcome at 3 months after thrombolytic therapy.
Jantasri S; Tiamkao S; Sawanyawisuth K
Clin Neurol Neurosurg; 2020 Nov; 198():106206. PubMed ID: 32932029
[TBL] [Abstract][Full Text] [Related]
8. The safety and effectiveness of low-dose recombinant tissue plasminogen activator (0.6 mg/kg) therapy for elderly acute ischemic stroke patients (≥ 80 years old) in the pre-endovascular era.
Takayanagi S; Ochi T; Hanakita S; Suzuki Y; Maeda K
Neurol Med Chir (Tokyo); 2014 Jun; 54(6):435-40. PubMed ID: 24670312
[TBL] [Abstract][Full Text] [Related]
9. Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy.
Inohara T; Liang L; Kosinski AS; Smith EE; Schwamm LH; Hernandez AF; Bhatt DL; Fonarow GC; Peterson ED; Xian Y
J Am Heart Assoc; 2019 Aug; 8(15):e012450. PubMed ID: 31327296
[TBL] [Abstract][Full Text] [Related]
10. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
[TBL] [Abstract][Full Text] [Related]
11. Computed Tomography Angiography in Acute Stroke Patients Receiving Recombinant Tissue Plasminogen Activator: Outcome and Safety Evaluations in an Asian Population.
Lin CM; Wu HC; Wu YM; Liu CH; Chang KH; Chang TY; Huang KL; Chang YJ; Lee TH; Tsay PK; Cheng CK; Chang CH
Cerebrovasc Dis; 2020; 49(1):62-69. PubMed ID: 32023610
[TBL] [Abstract][Full Text] [Related]
12. Safety of intravenous thrombolysis for ischemic stroke in patients with hematologic malignancies: A single institution experience.
Rael S; Webb M; Brown RD; Ruff MW; Keser Z; Sener U
J Stroke Cerebrovasc Dis; 2023 Sep; 32(9):107294. PubMed ID: 37562180
[TBL] [Abstract][Full Text] [Related]
13. Effect of intravenous thrombolysis in acute ischemic stroke patients with cerebral microbleeds and analysis of risk factors for hemorrhagic transformation.
Lei YS; Li H; Lei JY; Li SX; Li DF
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):779-786. PubMed ID: 35179744
[TBL] [Abstract][Full Text] [Related]
14. Safety and Outcome of Decompressive Hemicraniectomy After Recombinant Tissue Plasminogen Activator Thrombolysis for Acute Ischemic Stroke: A Systematic Review.
Pedro KM; Roberto KT; Chua AE
World Neurosurg; 2020 Dec; 144():50-58. PubMed ID: 32822948
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of asymptomatic recombinant tissue plasminogen activator associated intracranial hemorrhage.
Teekaput C; Thiankhaw K; Tanprawate S; Teekaput K; Chai-Adisaksopha C
PLoS One; 2022; 17(8):e0272257. PubMed ID: 35913922
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Intravenous rtPA in Ischemic Strokes Due to Small-Vessel Occlusion: Systematic Review and Meta-Analysis.
Karaszewski B; Wyszomirski A; Jabłoński B; Werring DJ; Tomaka D
Transl Stroke Res; 2021 Jun; 12(3):406-415. PubMed ID: 33641037
[TBL] [Abstract][Full Text] [Related]
17. Cerebral edema in acute stroke: Effect of thrombolytic treatment.
Frisullo G; Bellavia S; Scala I; Rizzo PA; Broccolini A; Brunetti V; Pepe M; Pilato F; Morosetti R; Marca GD; Calabresi P
J Neurol Sci; 2022 May; 436():120206. PubMed ID: 35259555
[TBL] [Abstract][Full Text] [Related]
18. The First 10 Thrombolysis for Acute Ischemic Stroke in Lao People's Democratic Republic under Teleconsultation from Thailand.
Chutinet A; Keosodsay S; Vorasayan P; Samajarn J; Akarathanawat W; Kijpaisalratana N; Norsakpeseuth N; Phetsiriseng K; Thongsna S; Vongvasinkul P; Suwanwela NC
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104327. PubMed ID: 31530479
[TBL] [Abstract][Full Text] [Related]
19. Iodinated Contrast Agents Reduce the Efficacy of Intravenous Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients: a Multicenter Cohort Study.
Chen Z; Xu C; Zhong W; Gong X; Hu H; Zhang X; Chen Y; Li Q; Luo Z; Chen Z; Lou M
Transl Stroke Res; 2021 Aug; 12(4):530-539. PubMed ID: 32895894
[TBL] [Abstract][Full Text] [Related]
20. Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.
Guo C; Bai Q; Zhao Z; Zhang J
Cerebrovasc Dis; 2019; 48(1-2):85-90. PubMed ID: 31587000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
